BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22820754)

  • 1. The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.
    Cao CY; Li YY; Zhou YJ; Nie YQ; Wan YJ
    Tohoku J Exp Med; 2012 Aug; 227(4):253-62. PubMed ID: 22820754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.
    Domenici FA; Brochado MJ; Martinelli Ade L; Zucoloto S; da Cunha SF; Vannucchi H
    Gene; 2013 Oct; 529(2):326-31. PubMed ID: 23891824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: a meta-analysis.
    Wang J; Guo X; Wu P; Song J; Ye C; Yu S; Zhang J; Dong W
    Gene; 2013 Oct; 528(2):328-34. PubMed ID: 23891820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people.
    Hui Y; Yu-Yuan L; Yu-Qiang N; Wei-Hong S; Yan-Lei D; Xiao-Bo L; Yong-Jian Z
    Liver Int; 2008 Mar; 28(3):385-92. PubMed ID: 17999673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India.
    Bhatt SP; Nigam P; Misra A; Guleria R; Luthra K; Pandey RM; Pasha MA
    Gene; 2013 Jan; 512(1):143-7. PubMed ID: 23031808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTTP polymorphisms and susceptibility to non-alcoholic fatty liver disease in a Han Chinese population.
    Peng XE; Wu YL; Lu QQ; Hu ZJ; Lin X
    Liver Int; 2014 Jan; 34(1):118-28. PubMed ID: 23738963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD.
    Gawrieh S; Marion MC; Komorowski R; Wallace J; Charlton M; Kissebah A; Langefeld CD; Olivier M
    Dig Dis Sci; 2012 Apr; 57(4):952-7. PubMed ID: 22160635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus.
    Saremi L; Lotfipanah S; Mohammadi M; Hosseinzadeh H; Fathi-Kazerooni M; Johari B; Saltanatpour Z
    Cell Mol Biol Lett; 2019; 24():12. PubMed ID: 30923554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people.
    Zhou YJ; Li YY; Nie YQ; Yang H; Zhan Q; Huang J; Shi SL; Lai XB; Huang HL
    J Gastroenterol Hepatol; 2010 Apr; 25(4):772-7. PubMed ID: 20492333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction Between AGTR1 and PPARγ Gene Polymorphisms on the Risk of Nonalcoholic Fatty Liver Disease.
    Zhu P; Lu H; Jing Y; Zhou H; Ding Y; Wang J; Guo D; Guo Z; Dong C
    Genet Test Mol Biomarkers; 2019 Mar; 23(3):166-175. PubMed ID: 30793973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis.
    Xie R; Tang S; Yang Y
    J Diabetes Complications; 2022 Oct; 36(10):108261. PubMed ID: 36055011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population.
    Yang Z; Wen J; Li Q; Tao X; Ye Z; He M; Zhang W; Huang Y; Chen L; Ling C; Qu S; Hu R
    Mol Cell Endocrinol; 2012 Jan; 348(1):255-9. PubMed ID: 21939732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study.
    Dongiovanni P; Rametta R; Fracanzani AL; Benedan L; Borroni V; Maggioni P; Maggioni M; Fargion S; Valenti L
    BMC Gastroenterol; 2010 Sep; 10():102. PubMed ID: 20825652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China.
    Su Y; Liu Z; Yang L; Li Y; Jiang S; Yao H; Du G
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):894-904. PubMed ID: 32505733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.
    Hsieh CJ; Wang PW; Hu TH
    PLoS One; 2015; 10(6):e0127521. PubMed ID: 26042596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.
    Lee YH; Bae SC; Song GG
    Genet Test Mol Biomarkers; 2014 May; 18(5):341-8. PubMed ID: 24697566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High carbohydrate and noodle/meat-rich dietary patterns interact with the minor haplotype in the 22q13 loci to increase its association with non-alcoholic fatty liver disease risk in Koreans.
    Park S; Kang S
    Nutr Res; 2020 Oct; 82():88-98. PubMed ID: 32977255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the peroxisome proliferator-activated receptor-γ (rs1801282) and its coactivator-1 (rs8192673) are associated with obesity indexes in subjects with type 2 diabetes mellitus.
    Kruzliak P; Haley AP; Starcevic JN; Gaspar L; Petrovic D
    Cardiovasc Diabetol; 2015 Apr; 14():42. PubMed ID: 25928419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
    Mehta R; Shaw G; Masschelin P; Felix S; Otgonsuren M; Baranova A; Goodman Z; Younossi Z
    PLoS One; 2018; 13(6):e0199294. PubMed ID: 29928018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two genetic variants in FABP1 and susceptibility to non-alcohol fatty liver disease in a Chinese population.
    Peng XE; Wu YL; Lu QQ; Hu ZJ; Lin X
    Gene; 2012 May; 500(1):54-8. PubMed ID: 22465531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.